Strategic Focus Longitude Capital concentrates on venture growth investments in biotechnology, medical technology and health solutions, presenting opportunities to engage with portfolio companies at scaling stages seeking funding, partnerships or exits.

Recent Investments Active deal activity with recent rounds including cAMPfield Therapeutics, Cohere Health, OrsoBio, Opna Bio and CG Oncology signals ongoing appetite for growth-stage biotech and health tech companies that may need follow-on rounds, strategic collaborations or exits.

Portfolio Synergy Coordinate outreach with Longitude’s portfolio network across oncology, inflammatory disease and health solutions to identify co-investment or co-development opportunities, leveraging their ecosystem for partnerships and strategic alliances.

Scale and Exit As a growth-focused investor, Longitude seeks companies ready for scale or strategic exit events; identifying potential valuation inflection points and preparing tailored investment theses can align with their timing for follow-on rounds or liquidity events.

Geographic and Sector Reach Based in Menlo Park with a global portfolio, target companies in biotechnology, medical devices and health IT that align with their thesis, emphasizing opportunities in biopharma, diagnostics, and digital health to fit their fund size and stage preferences.